Howie came accross very well in the webinar.
Howie himself sees the current price as a bargain opportunity. Be nice to see management dip in here.
Howie also made it very clear there was enough cash runway into approval.
The opportunity cost of money sitting in this is what is holding punters away. However there is no clearer opportuntiy than Botanix at sub 200 mill market cap, given forecasted sales and market penetration of SOFDRA in overseas markets.
People read too much into this CRL. It is the lightest response you could get, the pathway here is clear. Whilst frustrating that we are delayed, I'm not sure many on here behind their keyboards could navigate a product into FDA approval. Management still found this asset in a depressed market and have negotiated it to get to this point. Being on the ASX ironically has allowed for this to get this far (not to mention the R&D Incentives) BIO's in the US are struggling to raise money.
We are not even being valued for BTX1801, BTX 1503 or anything else either, ridiculous really.
Onwards and upwards.
Howie came accross very well in the webinar.Howie himself sees...
-
- There are more pages in this discussion • 4,321 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.015(4.76%) |
Mkt cap ! $597.3M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.3¢ | $1.265M | 3.862M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 129446 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 131308 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |